Comparative outcome in different dosage of intra-articular steroid injection for symptomatic osteoarthritis of hip, a randomized control trial of multicenter study

Phase 4

• Conditions: Hip osteoarthritis; Hip steroid injection

• Registration Number: TCTR20220301001
• Lead Sponsor: Thai Orthopedic Society for Sports Medicine (TOSSM)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-03-01
• Study Completion: 2024-03-14
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 130

Inclusion Criteria

1. primary and secondary osteoarthritis of hip in Tonnis classification 1-3 with failure conservative treatment more than 4 weeks.
(If bilateral involvement, evaluated the main site or injection site)
2. age between 40-80 years
3. no history of previous hip surgery
4. no history of hip injection within 1 year before enrollment
5. understand well in Thai language and can made self-decision

Exclusion Criteria

1. uncontrolled and poor-controlled diabetic mellitus
2. history of infection around the hip joint
3. osteonecrosis of hip
4. Inflammatory hip arthritis such as Ankylosing Spondylitis, Sero-Negative Spondyloarthropathy, rheumatoid arthritis
5. allergy to anesthetic agents or steroid
6. pregnancy (by history taking if LMP)
7. history of degenerative spine disease with significant radicular pain or neurological deficit
8. evidence of osteolytic or osteoblastic lesion around the hip
9. planning for hip replacement within 6 months

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
EQ5D-VAS 2, 6 , 12, 18, 24 weeks 0-100 scale,HOOS 2, 6 , 12, 18, 24 weeks scale,mHHS score 2, 6 , 12, 18, 24 weeks scale

Secondary Outcome Measures

Name	Time	Method
VAS pain 2, 6 , 12, 18, 24 weeks 0-10 scale